Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

19. ACR COVID-19 Vaccine Guidance Recommends Vaccination, Addresses Immunosuppressant Drugs & Patient Concerns

19. ACR COVID-19 Vaccine Guidance Recommends Vaccination, Addresses Immunosuppressant Drugs & Patient Concerns

FromACR on Air


19. ACR COVID-19 Vaccine Guidance Recommends Vaccination, Addresses Immunosuppressant Drugs & Patient Concerns

FromACR on Air

ratings:
Length:
41 minutes
Released:
Feb 10, 2021
Format:
Podcast episode

Description

This show is a special one and covers a topic that so many of you have been asking about! The American College of Rheumatology just released its guidance on the COVID-19 vaccine for patients with rheumatic diseases, and we have the lead author, Dr. Jeff Curtis, on with our host to discuss the research and recommendations.      Throughout the show, you will hear Dr. Curtis the ACR’s recommendation that all patients with rheumatic diseases should get the vaccine and that it does not matter which one you get—just make sure your second dose is by the same brand. Bottom line: get whichever one is available to you as soon as you can get it.   They also discuss the process of developing the ACR guidance, the experts involved including epidemiologists, rheumatologists, and infectious disease clinicians; and how they plan to keep the document updated.   And finally, they discuss the safety and efficacy of the vaccines despite how rapidly they were developed, the low risk of disease flares, and the importance of ongoing research on this topic.   This is the episode you want to listen to NOW!  
Released:
Feb 10, 2021
Format:
Podcast episode

Titles in the series (86)

As the official podcast of the American College of Rheumatology (ACR), ACR on Air seeks to have informative and engaging conversations rheumatology professionals want to hear – ranging in topic from trends in clinical practice, to issues affecting rheumatology professionals, and the changing landscape of the rheumatology field. Tune in each month for engaging interviews and commentary.